RF182

N/A

Report date: 2025/07/07 16:51:26
NME

Base Information

Drug NameRF182
Drug Alias NameRF182RF-182
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRuifu Pharmaceutical Technology (Guangzhou) Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesRuifu Pharmaceutical Technology (Guangzhou) Co., Ltd.
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A